The two firms first joined forces in 2005 to identify and create enzymes for the "cost-effective production of a proprietary food-related product designed to help global consumers pursuing healthy lifestyles". Under terms of the agreement, Diversa received upfront payments and research funding, and was also entitled to receive milestone payments, license fees, and royalties on products that may be developed. Yesterday, the groups expanded the scope of their collaboration, after Diversa completed the first phase "ahead of schedule and with technologically superior results," according to the firm. The companies now say they plan to develop additional enzymes to facilitate the next steps of production. The move "underscores the successful synergy between Diversa's enzyme development platforms and Cargill's bioprocessing capabilities and interests," according to Edward Shonsey, Diversa's chief executive officer. "It also accentuates Diversa's ability to efficiently provide custom enzyme solutions to our partners and collaborators in many different industries. Our extensive libraries of enzymes hold many novel solutions just waiting to be discovered. We are excited to expand this relationship and look forward to building future collaborations with Cargill in other strategic areas of mutual interest," he added. And according to Cargill's Chris Mallett, corporate vice president, research and development, "this collaboration with Diversa has produced successful results ahead of our targeted timeline." "Our combined research teams are to be congratulated for meeting a key technical milestone. We look forward to implementing our expanded agreement and to the future success of this project," he added.